Abstract
Multiple sclerosis is a fatal neurodegenerative disease that progresses by eroding the myelin sheath and exposing the neuron, leading to neuronal degradation and death. While multiple sclerosis remains without an effective treatment or cure, studies have identified genes that are dysregulated in multiple sclerosis patients and predicted to be involved with disease progression. These genes are primarily involved in controlling DNA methylation, a process required for regulating gene expression that is critical for cellular health. Having identified potential genetic risk factors, current research focuses on how to manipulate the expression of these genes, offsetting DNA methylation errors in patients by targeting DNA secondary structure formation. Serine hydroxymethyltransferase 1 (SHMT1) is a key player in DNA methylation and was determined to be upregulated in multiple sclerosis patients. Here, we characterized hybrid 3 + 1 G-quadruplex (GQ) and i-motif (iM) structures in the SHMT1 DNA 5′ untranslated region and a parallel GQ in the corresponding mRNA. Additionally, we found that the GQ/iM structures suppress the mRNA levels and protein expression of a reporter gene. Together, these data suggest that GQ/iM structures are necessary for SHMT1 regulation, which could serve as a target for therapeutic intervention for multiple sclerosis patients.


Introduction
Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease of the central nervous system that directly targets and destroys the protective myelin sheath. MS, which is currently incurable, affects ∼2.8 million people worldwide, with patients typically being diagnosed between the ages of 20 and 50 years, three-quarters of whom are women. Symptoms include vision loss due to optic neuritis, ataxia, paresthesia, pain, and fatigue, with roughly half of MS patients also experiencing cognitive impairment. The exact cause of MS remains unknown, but a combination of genetic and/or environmental factors (low vitamin D, obesity, smoking, viral infection, etc.) are suspected to contribute. Since only about a quarter of MS patients have known MS genetic risk loci, dysregulation at the epigenetic level through DNA methylation, histones, and other proteins may play an important role in the etiology of the disease. ,
DNA methylation, or the methylation of cytosines located at CpG sites to 5-methyl-cytosine (5-mC), typically represses gene expression. The exact mechanism by which DNA methylation silences gene expression is not fully understood, but two possibilities have been proposed: (i) formation of 5-mC prevents the binding of transcription factors to their target sites or (ii) DNA-binding proteins containing methylated DNA-binding domains bind to 5-mC and recruit transcriptional silencing complexes. Genome-wide association studies (GWAS) comparing gene expression in patients with different types of MS to healthy patient controls have identified changes in DNA methylation patterns as a common factor. , Additionally, studies have identified that proteins involved in regulating DNA methylation are abnormally expressed in MS patients, including serine hydroxymethyltransferase 1 (SHMT1), solute carrier family 19 member 1 (SLC19A1), DNA methyltransferases (DNMTs), , ten-eleven translocases 1 to 3 (TET1-3), , and methylated DNA binding domain 2 protein (MBD2). In this study, we focused on SHMT1, since the SHMT1 rs4925166 single nucleotide polymorphism has been identified as a susceptibility locus for MS, and a subsequent study determined the upregulation of SHMT1 in white matter lesions of MS patients. ,
SHMT1 contributes to DNA methylation via participation in the folate cycle by regulating the availability of the methyl donor S-adenosylmethionine (SAM). SHMT1 catalyzes the conversion of tetrahydrofolate (THF) to 5,10-methylene THF (5,10-mTHF) via the addition of a single carbon (Figure ). , 5,10-mTHF is then processed into 5-methyl THF (5-mTHF), the methyl donor for methionine formation from homocysteine. Methionine is critical for DNA methylation, as it is the precursor to SAM, one of the most prolific methyl donors in the cell. The increased expression of SHMT1 in MS patients could indicate a possible correlation between the expression of this gene and the abnormal DNA methylation status. , Therefore, understanding the regulatory mechanisms of SHMT1 expression could lead to a potential new target for MS therapeutic intervention.
1.

Role of SHMT1 in the DNA methylation cycle. SHMT1 catalyzes the conversion of tetrahydrofolate (THF) to 5,10-methylene THF (5,10-mTHF), which is then methylated to become 5-methyl THF (5-mTHF) by methylenetetrahydrofolate reductase (MTHFR). 5-mTHF enters the methionine cycle as a precursor to S-adenosylmethionine (SAM), a prolific methyl donor necessary for DNA methylation in the cell. 5-mTHF is converted back into THF by methionine synthase (MS) to complete the folate cycle. In the methionine cycle, production of SAM is achieved via the methylation of homocysteine (Hcy) to methionine (Met), which is then converted into the final methyl donor SAM.
An emerging route for new treatments is transcriptional and translational control of gene expression via noncanonical DNA/RNA secondary structures, such as guanine-quadruplexes (GQs) and intercalated-motifs (iMs). GQs and iMs are rich in guanines or cytosines, respectively, and rely on noncanonical hydrogen bonding base pair formation. GQs are formed within DNA or RNA sequences with at least four G-tracts (G≥3N x G≥3N x G≥3N x G≥3) that are separated by loops of variable nucleotide length (x = 1 to 12). Four Gs engage in Hoogsteen base pairing, forming G-tetrads that stack upon each other and are stabilized by central potassium ions. , GQs are prevalent in the human genome, with over 700,000 unique GQs (with loops of 1–12 nucleotides) predicted to form with high density in promoters, 5′ untranslated regions (5′UTRs), and splicing sites. , iMs are formed by the hemiprotonation of cytosine bases, which allows two cytosines to hydrogen bond and intercalate upon another C–C base pair. , Hemiprotonation occurs only at low pH (4.0–6.0), causing iM formation in vivo to be debated. However, a recent study identified over 53,000 iM structures at the same genomic sites across three different human cell lines, likely due to molecular crowding and/or the presence of magnesium ions. , While it has been shown that steric hindrance prevents GQs and iMs from forming simultaneously directly across from each other, sequences that have more than four G-rich and C-rich repeats can form simultaneously in a staggered fashion.
It is well-established that these noncanonical nucleic acid secondary structures regulate gene expression both at the transcriptional and translational levels. In general, DNA GQs have been found to inhibit transcription, while iMs activate it, but this trend is not universal. In some cases, GQs are suggested to form “binding hubs” for transcription factors that upregulate gene expression, and some iMs have been found to repress transcription. , Thus, in a gene-dependent manner, DNA GQ and iM structures could function as molecular switches for controlling transcriptional regulation. Moreover, GQs formed in RNA have been found to regulate mRNA translation, alternative splicing, 3′-end processing, and alternative polyadenylation. −
Here, we analyzed SHMT1 for sequences that could form GQ/iMs and identified a region within its 5′UTR that exhibited strong potential for DNA GQ/iM and RNA GQ formation. Given this, we hypothesized that DNA GQ/iM and RNA GQ structures form in the 5′UTR of SHMT1 and regulate its expression. We used biophysical methods to show that the G-rich sequence in the SHMT1 DNA 5′UTR forms a stable hybrid 3 + 1 GQ exhibiting potassium-dependent stability. The complementary SHMT1 DNA C-rich sequence forms an iM structure that is highly stable at pH values of 4.0 and 5.5. Additionally, we found that the corresponding G-rich mRNA sequence forms a parallel GQ stabilized in the presence of potassium. Moreover, through luciferase reporter assays, we demonstrate that these noncanonical structures suppress gene expression, potentially acting as a molecular switch that could be targeted for therapeutic intervention against MS.
Results and Discussion
The SHMT1 5′UTR DNA G-Rich Sequence Forms a Stable Hybrid 3 + 1 G-Quadruplex Structure in the Presence of Potassium Ions
Given that MS patients exhibit altered DNA methylation, we analyzed genes involved in the methylation pathway for regions that could fold into GQ structures and identified a 25-nucleotide-long G-rich region in the 5′UTR of the SHMT1 gene. When assessed with the GQ-predictive QGRS Mapper software, this sequence was predicted to form a GQ structure (G-score: 40). The G-score rewards a larger number of Gs within a repeat and shorter intervening loops. For reference, the highest possible predicted G-score by this software for a 30-nucleotide sequence is 105, corresponding to a GQ with six G quartets, and we previously characterized three-plane GQs with predicted G-scores of ∼40 and four-plane GQs with predicted G-scores of ∼55. Therefore, given its high predicted propensity to fold into a GQ, the SHMT1 DNA G-rich sequence (named here SHMT1 DNA GR, Table ) was characterized by various biophysical methods.
1. SHMT1 DNA, SHMT1 DNA Mutant, and SHMT1 mRNA Sequences as well as GQ-Positive and -Negative Controls Used in This Study .
| Gene name | Structure | Sequence |
|---|---|---|
| SHMT1 DNA GR | GQ | 5′-GGGGCGTTGGG TCAGC GGGTCTGGG -3′ |
| SHMT1 DNA CR | iM | 3′-CCCCGCAACCC AGTCG CCCAGACCC -5′ |
| SHMT1 GR_MUT | GQ mutant | 5′-GACGCGTTGAT TCAGC CTGTCTGAC -3′ |
| SHMT1 CR_MUT | iM mutant | 3′-CTGCGCAACTA AGTCG GACAGACTG -5′ |
| SHMT1 RNA GR | GQ | 5′-GGGGCGUUGGGUCAGCGGGUCUGGG-3′ |
| BDNF RNA | GQ+ control | 5′-GGGAUGGGGGAUGGGGGG-3′ |
| NEAT1 RNA | GQ+ control | 5′-GGGAGGGAGGGAGGGAGGCGG-3′ |
| SARS-CoV-2 open reading frame 1a | GQ– control | 5′-GACUGUAGUGCGCGUC-3′ |
| SARS-CoV-2 s2m | GQ– control | 5′-UCACCGAGGCCACGCGGAGUACGAUCGAGUGUACAG UGAA-3′ |
The Gs highlighted in bold are predicted to form GQs, and the Cs highlighted in bold are predicted to form iMs. The underlined nucleotides were mutated to disrupt GQ/iM formation.
We first used one-dimensional (1D) proton nuclear magnetic resonance (1H NMR) spectroscopy to determine if SHMT1 DNA GR formed a GQ by monitoring the imino proton resonance region between 10 and 12 parts per million (ppm), which corresponds to G imino protons involved in Hoogsteen base pairs within the G-tetrads. , We observed multiple imino proton resonances in the 10–12 ppm range, even in the absence of potassium ions, indicative of the formation of the GQ structure (Figure A). Upon the addition of 10 mM KCl, the appearance of a new set of resonances was observed, and with each subsequent addition of KCl, the new resonances increased in intensity with a concomitant decrease in intensity of some of the resonances observed at 0 mM KCl. These results suggest that the addition of potassium ions promotes the formation of a different GQ structure, unique from the one formed in the absence of potassium.
2.

(A) KCl dependence of 1D 1H NMR spectroscopy of the SHMT1 DNA GR sequence. In the absence of KCl, resonances in the 10–12 ppm range are indicative of GQ formation. Significant resonance changes occur upon the addition of 10 mM KCl, and the intensity of these resonances increases with increasing KCl concentration, suggesting a change to the GQ structure further stabilized by KCl. (B) KCl dependence of 1D 1H NMR spectroscopy of the SHMT1 GR_MUT sequence. Mutation of critical nucleotides in the G-tracts results in loss of the GQ resonances in the 10–12 ppm region and appearance of resonances corresponding to Watson–Crick base pairing (12–14.5 ppm). (C) KCl dependence of CD spectroscopy results of the SHMT1 DNA GR sequence. In the absence of KCl, a characteristic antiparallel GQ signature is observed (∼295 nm max, ∼260 nm min). Upon addition of KCl, the signature shifts to that of a stable 3 + 1 hybrid GQ structure (∼295 and ∼265 nm max, ∼240 nm min), which persists to 150 mM KCl.
To confirm that the predicted G-repeats are responsible for the GQ structure, we designed a control mutant SHMT1 GR sequence which had several Gs mutated (SHMT1 GR_MUT, Table ). As expected, analysis by 1H NMR spectroscopy revealed that the broad imino proton resonances present in SHMT1 DNA GR in the 10–12 ppm range are absent from the spectra of SHMT1 GR_MUT at both 0 and 150 mM KCl (Figure B). In contrast, imino proton resonances in the 12–14.5 ppm region, corresponding to Watson–Crick base pairing, are present at 0 mM KCl and become sharper at 150 mM KCl, indicating hairpin or duplex structure formation. We analyzed potential unimolecular and bimolecular folds of this sequence using RNAstructure software, which suggested stable intramolecular hairpin and intermolecular duplex structures which could give rise to these resonances in the NMR spectra (Figure S1). These results demonstrate that the mutated nucleotides disrupt the G-tracts of this sequence and prevent the formation of the GQ structure even at 150 mM KCl.
Next, we used circular dichroism (CD) spectroscopy to characterize the orientation of the GQ structure, as CD spectra can differentiate between the three unique GQ conformations (parallel, antiparallel, and hybrid 3 + 1). , A parallel GQ structure exhibits a positive maximum at 265 nm and a negative minimum at 240 nm, while an antiparallel formation results in a positive maximum at 295 nm and a negative minimum at 260 nm. A hybrid 3 + 1 GQ conformation gives rise to positive maxima at ∼295 nm and ∼260 nm with a negative minimum at ∼245 nm. The spectrum of SHMT1 DNA GR in the absence of potassium exhibited the characteristic signature of an antiparallel GQ, with a positive maximum at ∼295 nm and a negative minimum at ∼260 nm (Figure C). However, upon the addition of KCl, the spectrum shifted significantly, resulting in positive maxima at ∼295 and 265 nm with a negative minimum at ∼240 nm. Further additions of KCl caused a slight increase in the intensity of the positive bands at 295 and 265 nm. These results correlate with a GQ structure that shifts from an antiparallel orientation to a stable hybrid 3 + 1 orientation in the presence of potassium ions. This finding is consistent with our 1H NMR results, which indicated a conformational change to the GQ structure that is further stabilized by increasing KCl concentrations.
Next, we analyzed the SHMT1 DNA GR GQ by native polyacrylamide gel electrophoresis (PAGE) in the presence of increasing KCl concentrations. When the gel was stained with N-methylmesoporphyrin IX (NMM), which has been shown to only effectively stain parallel GQs, , no visible bands were observed in the lanes containing SHMT1 DNA GR samples even though a GQ-positive control was visible (Figure S2). Although SHMT1 DNA GR forms two distinct and stable GQ conformations, neither is stained by NMM, which supports the formation of an antiparallel GQ that shifts into a hybrid 3 + 1 conformation in the presence of potassium ions.
Finally, we used ultraviolet (UV) thermal denaturation spectroscopy to evaluate the effect of potassium ions on the stability of SHMT1 DNA GR by monitoring the change in absorbance at 295 nm with increasing temperature. At all KCl concentrations investigated, the SHMT1 DNA GR denaturation gave rise to a hypochromic transition, the signature of GQ dissociation (Figure A). In the absence of KCl, the melting temperature, T m, was determined to be ∼35 °C (eqs and , Materials and Methods), increasing to 56 °C after the addition of 10 mM KCl (Table S1). This result suggests that the hybrid 3 + 1 GQ formed by SHMT1 DNA GR in the presence of KCl is significantly more stable than the antiparallel GQ formed in the absence of potassium ions. Moreover, the T m of the hybrid 3 + 1 GQ further increased in the presence of increasing KCl concentrations, reaching ∼71 °C at 150 mM KCl (Table S1).
3.
(A) KCl dependence of UV thermal denaturation of the SHMT1 DNA GR sequence. Hypochromic transitions of GQ unfolding are observed at each KCl concentration, with each titration subsequently displaying a higher T m, indicating KCl-dependent stability. (B) Plot of ΔG° versus log[K+] for SHMT1 DNA GR UV thermal denaturation. The slope of the graph, n, is equal to the average number of potassium ions intercalated into the SHMT1 DNA GQ structure.
The standard enthalpy, entropy, and free energy (ΔH°, ΔS°, ΔG°) of the SHMT1 DNA GR folding were calculated by fitting the hypochromic transition measured in the presence of each KCl concentration to eq , which assumes a two-state model, and are reported in Table S1. Reported values for the enthalpy of formation of a single G-quartet plane are from −18 to −25 kcal/mol, which, compared to our results of −64.7 ± 0.1 kcal/mol for 150 mM KCl, suggest that SHMT1 DNA GR forms a three-plane GQ structure. From the slope of the calculated free energy of the GQ structure folding, plotted as a function of the logarithm of the KCl concentration (Figure B), we estimate that there are ∼2.5 K+ ions incorporated in the SHMT1 DNA GQ structure, which is consistent with a three-plane GQ (eq , Materials and Methods). In summary, we show that in the presence of KCl, SHMT1 DNA GR forms a stable hybrid 3 + 1 GQ structure, which coordinates on average ∼2.5 K+ ions.
The SHMT1 5′UTR DNA C-Rich Sequence Forms a Stable i-Motif Structure
The C-rich SHMT1 sequence (named here SHMT1 DNA CR, Table ), complementary to the G-rich sequence forming a GQ, was analyzed for its potential to fold into an iM structure by using biophysical methods. These experiments were performed at varying pH values because iM formation relies on the hemiprotonation of one cytosine in each structural base pair.
We first used 1D 1H NMR spectroscopy, since hemiprotonated cytosines in iM structures give rise to unique proton resonances in the 15–16 ppm range. The 1H NMR spectra of SHMT1 DNA CR at pH 4.0 and 5.5 showed resonances in the 15–16 ppm range (Figure A). We also observed two resonances in the 10.4–10.6 ppm range, which we attribute to G–G or T–T interactions made possible by the loops of the iM structure. At pH 6.5, the resonances in the region 15–16 ppm lose intensity, suggesting the destabilization of the iM structure, with the concomitant appearance of multiple new resonances in the region 12–14.5 ppm. This range corresponds to Watson–Crick A–T and G–C base pairs that become possible at this higher pH, potentially forming between the loops of the iM structure. However, these resonances are broad and have low intensity, suggesting that these loop–loop interactions are dynamic and transient in nature. At pH 7.0, both the iM and the Watson–Crick resonances are lost, indicating that the Watson–Crick base pairing was dependent on the presence of the iM structure scaffold and that SHMT1 DNA CR lacks any secondary structure under these conditions.
4.

(A) pH dependence of 1D 1H NMR spectroscopy of the SHMT1 DNA CR sequence. In acidic conditions (pH 4.0, 5.5), resonances are present in the 15–16 ppm range, indicative of iM formation. At pH 6.5, the iM resonances lose intensity, and Watson–Crick resonances appear (12–14 ppm). At pH 7.0, the iM resonances are lost. (B) KCl dependence of 1D 1H NMR spectroscopy of the SHMT1 CR_MUT sequence. Mutation of critical nucleotides in the C-tracts results in loss of the iM resonances in the 15–16 ppm region and appearance of Watson–Crick resonances in the 12–14 ppm range. (C) pH dependence of CD spectroscopy results of the SHMT1 DNA CR sequence. The strong iM signature (290 nm max, 260 nm min) at pH 4.0 and 5.0 is gradually lost at pH 6.5 and is fully eliminated at pH 7.0. (D) pH dependence of UV thermal denaturation results of the SHMT1 DNA CR sequence. The hypochromic transition at pH 5.5 corresponds to the denaturation of the iM structure. The pH 4.0 iM structure was too stable to denature under these conditions.
In control experiments, we mutated SHMT1 DNA CR to disrupt the C-tracts predicted to be involved in iM formation (SHMT1 CR_MUT, Table ). As expected, the iM signature resonances in the 15–16 ppm region are absent from the 1D 1H NMR spectrum of SHMT1 CR_MUT at pH 4.0 (Figure B). Multiple resonances are present in the ∼11–14.5 ppm range at both pH 4.0 and 7.0, suggesting that this sequence forms A–T, G–C, and G–T base pairs. RNAstructure analysis of the SHMT1 CR_MUT sequence predicted intramolecular hairpin and intermolecular duplex formation, which could account for the resonances in the Watson–Crick range (Figure S3). These results confirm that the selected nucleotide mutations within the C-tracts of this sequence effectively eliminate the formation of iM structures, even at low pH levels.
To further characterize the SHMT1 DNA CR iM structure, we used CD spectroscopy, as iM structures have a distinct CD signature with a positive maximum at 290 nm and a negative minimum at 260 nm. At pH 4.0 and 5.5, the SHMT1 DNA CR spectra showed a positive maximum at ∼290 nm and a negative minimum at ∼260 nm, indicating that the iM forms at low pH conditions (Figure C). However, at pH 6.5, the signal intensity dropped significantly, and the bands shifted to a positive maximum at ∼285 nm and a negative minimum near ∼240 nm. At pH 7.0, the iM signature is completely lost, and the bands shifted further to a positive maximum at ∼275 nm and a negative minimum at ∼240 nm. These results are consistent with the 1H NMR spectroscopy results, which indicated a stable iM structure at pH 4.0 and 5.5, which becomes destabilized at pH 6.5 and unfolded at pH 7.0.
We then evaluated the stability of the SHMT1 DNA iM structure at each pH level by UV thermal denaturation spectroscopy, as iM unfolding exhibits a hypochromic transition at 295 nm. At pH 4.0, the SHMT1 DNA CR iM structure was too stable to denature within the measured range, with minimal destabilization at the highest temperatures (Figure D). A full hypochromic curve was observed for SHMT1 DNA CR at pH 5.5, which was fit to eq to determine a T m of 49.9 ± 0.1 °C and the corresponding thermodynamic parameters for iM folding (Table S2). The curves at pH 6.5 and 7.0 show the end tail of a hypochromic transition, indicating that the iM is unstable at these pH values. Taken together, these data confirm the formation of an iM structure in SHMT1 DNA CR that is highly stable at pH 4.0 and 5.5.
The SHMT1 5′UTR mRNA G-Rich Sequence Forms a Stable Parallel G-Quadruplex Structure Even in the Absence of Potassium
Given that the SHMT1 DNA GR sequence is located on the coding strand, we investigated the possibility that the corresponding GR mRNA sequence could also form a GQ structure. Considering the emerging studies showing these secondary structures forming in mRNA 5′UTRs and acting as potential translational regulators, we implemented the same biophysical techniques to characterize this SHMT1 RNA GR sequence (Table ). The 1D 1H NMR spectra of SHMT1 RNA GR showed GQ-signature resonances in the 10–12 ppm region, even at 0 mM KCl (Figure A). These resonances initially became sharper upon the first addition of KCl, indicating GQ stabilization, after which they became broader with increasing KCl concentrations. We attribute the line broadening and loss of intensity of these resonances to intermolecular GQ stacking interactions stabilized by the high concentration of potassium ions. The formation of such higher-molecular-weight complexes leads to their slower tumbling and a faster relaxation of the transverse magnetization due to enhanced spin–spin interactions and hence the broadening and reduced intensity of the signal. No Watson–Crick resonances (12–14.5 ppm) were present at any KCl concentration, indicating no competing hairpin structure is formed by SHMT1 RNA GR.
5.

(A) KCl dependence of 1D 1H NMR spectroscopy of the SHMT1 RNA GR sequence. Imino proton resonances in the 10–12 ppm region, even in the absence of potassium, indicate stable GQ formation. (B) KCl dependence of CD spectroscopy of the SHMT1 RNA GR sequence. The RNA GQ exhibits characteristic parallel GQ signals of a ∼265 nm maximum and a 240 nm minimum under all KCl concentration conditions. (C) KCl dependence of the native PAGE of the SHMT1 RNA GR sequence. The presence of bands in the NMM staining of SHMT1 (lanes 1–6) compared to a positive GQ control (lane 7) confirms the GQ formation seen in the CD and NMR spectroscopy results.
Next, we used CD spectroscopy to determine the orientation of the SHMT1 RNA GQ. The spectra of the SHMT1 RNA GR were distinct from those of the SHMT1 DNA GR sample, exhibiting a positive maximum at ∼265 nm and a negative minimum at ∼240 nm (Figure B). This signature is characteristic of a parallel GQ conformation, compared to the antiparallel and hybrid 3 + 1 structures adopted by the corresponding DNA sample. This is not unexpected, though, as RNA GQs are restricted to parallel orientation by the hydroxyl group at the 2′ carbon position. , These results are consistent with the 1H NMR spectra, indicating that the RNA GQ retains the same conformation regardless of potassium concentration, unlike the DNA GQ, which shifts orientation in the presence of KCl.
Having determined that the SHMT1 RNA GQ folds in a parallel orientation, we analyzed it using native PAGE and staining with NMM dye. The samples were prepared in the presence of increasing concentrations of KCl and compared to a GQ-positive and a GQ-negative control. When stained with NMM (Figure C, left), lane 7 (containing the GQ-positive control) shows a dark band, while lane 8 (GQ-negative control) is not stained, validating the specificity of NMM staining of parallel GQs. NMM staining of SHMT1 RNA GR, lanes 1–6, revealed a lower-molecular-weight band that was visible in all samples, including when the RNA was incubated without added potassium, indicating the formation of a stable parallel GQ. The appearance of faint, higher-molecular-weight bands at KCl concentrations above 25 mM suggests the stacking of the SHMT1 RNA GQs. When visualized after ethidium bromide staining (Figure C, right), all RNA bands become visible, including the GQ-negative control band in lane 8.
To investigate the stability of SHMT1 RNA GR at each potassium concentration, we employed UV thermal denaturation spectroscopy. At each KCl concentration, a hypochromic transition corresponding to the denaturation of the SHMT1 RNA GQ structure was observed (Figure A), with T m values increasing from 51 °C at 0 mM to 77 °C at 150 mM KCl (Table S3). Assuming a two-state model, as for the SHMT1 DNA GQ, the data was fitted to eq to calculate thermodynamic parameters (Table S3). The enthalpy of formation for SHMT1 RNA GR at 150 mM KCl was calculated to be −82.9 ± 0.1 kcal/mol. The SHMT1 RNA GQ had higher enthalpy of formation values than the DNA GQ at all KCl concentrations. Additionally, SHMT1 RNA GR also exhibited higher melting temperatures under all potassium-dependent conditions. These findings are consistent with reports that RNA GQs are more thermodynamically stable than DNA GQs due to their preference for parallel GQ orientation. Finally, the number of potassium ions intercalated into the SHMT1 RNA GQ was found to be ∼3.4 (Figure B), from the slope of the plot of the calculated free energy of folding versus the logarithm of the potassium concentration (eq ). This value is consistent with at least a three-planar GQ structure. Generally, potassium ions are intercalated between the G-quartets, but there are crystal structure examples of GQs where an additional potassium ion interacts with the top G-quartet, which could explain the average of >3 potassium ions we determined for the SHMT1 RNA GQ.
6.
(A) KCl dependence of UV thermal denaturation results of the SHMT1 RNA GR sequence. Hypochromic transitions of GQ melting are observed at each KCl concentration, with T m values increasing with each KCl concentration. (B) Plot of log[K+] versus ΔG° for SHMT1 GR RNA UV thermal denaturation. When plotted as such, the slope of the graph is equal to the average number of potassium ions intercalated by the SHMT1 RNA GQ.
Transcriptional Regulation by the 5′-UTR of SHMT1
In summary, we showed that isolated SHMT1 DNA/RNA GR and CR sequences form stable GQ and iM structures in vitro. While these experiments were in progress, a study used antibodies to map out GQ and iM structures formed in the human genome in vivo. Interestingly, the SHMT1 DNA GR and CR sequences characterized here were also identified in this study for GQ and iM formation in cells, supporting the hypothesis that these structures might play a regulatory role in the expression of SHMT1. To test this, we assessed the impact of the full-length SHMT1 5′UTR on a firefly luciferase reporter gene. We constructed a plasmid that contained a Renilla luciferase and a firefly luciferase, where the wild-type (WT) or mutant SHMT1 5′UTR was cloned in front of the firefly luciferase gene. These plasmids were then transfected into A549 cells, and the relative luciferase activities were read after 72 h. We found that cells transfected with the WT SHMT1 5′UTR reporter had 36% less firefly luciferase activity compared to the mutant 5′UTR (Figure A), suggesting that the secondary structures of the SHMT1 5′UTR can suppress protein expression levels.
7.

(A) Impact of SHMT1 5′UTR on firefly luciferase expression. A 36% reduction in relative luciferase activity in the WT indicates that DNA/RNA secondary structures play a role in suppressing gene expression. (B) RT-qPCR assay highlighting the suppression of firefly luciferase mRNA levels. A 37% reduction in mRNA levels in the WT suggests that DNA secondary structures play a role in regulating transcription of luciferase. All data represent the mean and standard deviation of 3 biological replicates. P-values are indicated for (A) one-way analysis of variance (ANOVA) with Dunnett’s correction and (B) two-tailed Welch’s t-test between WT and mutant.
As the mutant sequence disrupts both the GQ and iM structures simultaneously at the DNA level as well as the GQ at the RNA level, we cannot determine if the DNA GQ/iM and/or RNA GQ structures are responsible for the observed reduction in firefly activity. Therefore, we assessed the impact of the SHMT1 DNA GR/CR sequence solely on the transcription of firefly luciferase by using RT-qPCR to determine relative mRNA levels as controlled by WT or mutant SHMT1 5′UTR sequences. Consistent with the protein activity assays, we found that cells transfected with the WT SHMT1 5′UTR reporter had 37% less firefly luciferase mRNA compared to the mutant 5′UTR (Figure B). Supporting the role of the SHMT1 5′UTR secondary structures in affecting luciferase transcription, the mutant sequence mRNA levels were comparable to the control pmirGLO-luciferase mRNA levels, which contained the wild-type luciferase 5′UTR (Figure B). Taken together, these data indicate that the GQ/iM secondary structures formed in the SHMT1 DNA 5′UTR sequence are necessary to mediate the expression of the reporter gene by reducing transcription. Although the SHMT1 RNA GR sequence forms a stable GQ structure in vitro, it is possible that the SHMT1 5′UTR mRNA GQ structure is not stable in the cell in the experimental conditions we used in this study, as it has been shown that stress promotes RNA GQ folding in cells, with this stress-induced folding being reversible upon stress removal. Thus, we cannot completely exclude additional regulation of SHMT1 translation by its 5′UTR RNA GQ in conditions of cellular stress, which are well documented in MS. ,
This characterization of GQ and iM structures in the SHMT1 5′UTR contributes to our understanding of how these secondary structures affect gene expression. While GQs and iMs are widely characterized in promoter regions, , their regulatory roles in the 5′UTR are not as well understood. Their positioning within the 5′UTR suggests a transcriptional or translational regulatory role, but detailed mechanisms remain elusive. ,, In our system, the presence of either, or both, secondary structures likely interferes with transcriptional machinery, resulting in lower overall mRNA levels and decreased expression of the SHMT1 protein. However, we acknowledge the limitations of our study in that our experiments were performed in a lung cancer cell line, which might not give a full picture of what happens in neurons. The regulatory effects of the GQ/iM structures are likely mediated via their interactions with proteins whose expression might differ in these two different cell types. For patients with MS, SHMT1 is overexpressed and contributes to abnormal DNA methylation. Our observation that SHMT1 GQ/iM formation results in decreased protein expression could constitute a novel therapeutic target via stabilization of the secondary structures. Currently, there are two primary tactics used for GQ/iM targeting in cells: small molecules and nucleic acid analogue oligonucleotides.
TMPyP4 is one of the most widely used GQ-binding ligands, known to bind these structures and inhibit telomerase activity but with noticeably poor selectivity for GQs versus duplex DNA. This issue was corrected in a modified ligand, TMPyPz, which exhibited not only higher GQ selectivity but also better telomerase inhibition. , Outside of telomere intervention, TMPyP4 and other GQ-binding ligands (pyridostatin and derivatives) were found to stabilize the formation of a GQ in the BAZ2B promoter in vitro. When treating the Alzheimer’s disease SH-SY5Y model cell line with these GQ ligands, Yang et al. observed a loss of BAZ2B expression that they tied directly to loss of transcription factor binding due to GQ stabilization. These small molecules are often not sequence-specific, though, with the potential to bind to a multitude of GQ-forming regions; because of this, nucleic acid analogue oligonucleotide interventions are gaining interest for the ability to design them complementary to any sequence of interest.
GQ or iM targeting oligonucleotides can be designed to stabilize or destabilize the secondary structures of interest, but because SHMT1 is upregulated in MS patients and because our results show an inhibitory effect due to GQ/iM formation, therapeutic intervention of this system would require stabilizing the SHMT1 5′UTR GQ/iM. One recent study designed a nucleic acid linker to stabilize the MYC promoter GQ, a structure that has been tied to decreased cancer progression by inhibiting protein expression. Psaras et al. designed an oligonucleotide with ends complementary to the sequences bordering the MYC GQ sequence, spaced by intermittent thymines to encompass the width of the GQ. This allowed the interfering DNA sequence to preferentially bind to MYC when the GQ is formed, stabilizing the structure in the process. Similar linkers could be designed for the SHMT1 system, targeting the regions bordering the DNA or RNA GQ to promote structure formation. Additionally, designing a linker targeting the C-rich border sequences could promote the formation of the iM structure and result in improved downregulation of SHMT1. The effect of such linker oligonucleotides upon the expression of SHMT1 will be tested in further studies in our laboratories. Thus, our study identifies novel potential therapeutic targets for the regulation of the SHMT1 expression while contributing to a growing library of 5′UTR GQ and iM structures with regulatory effects on gene expression.
Materials and Methods
The SHMT1 G/C-rich single-stranded DNA (ssDNA) sequences and G/C-rich mutant ssDNA sequences were chemically synthesized by Integrated DNA Technologies (IDT) (Table ). The corresponding G-rich mRNA sequence was chemically synthesized by Horizon Discovery (Table ). All sequences were suspended in 10 mM cacodylic acid (pH 6.5).
Native Polyacrylamide Gel Electrophoresis (PAGE)
SHMT1 DNA GR samples at a 20 μM concentration were prepared in the presence of varying concentrations of KCl (0, 10, 25, 50, 100, and 150 mM) in 1/2× Tris boric acid EDTA (TBE). The samples were boiled for 5 min and then cooled to 22 °C on the benchtop. A GQ-positive control sample was prepared from the brain-derived neurotropic factor (BDNF) mRNA in 150 mM KCl, and a GQ-negative control sample was prepared from the SARS-CoV-2 open reading frame (ORF) 1a RNA in 150 mM KCl (Table ). All samples were run in a 20% native polyacrylamide gel (30:0.8 acrylamide/bis(acrylamide)) for 4 h at 75 V and 4 °C in 1/2× TBE buffer. The gel was stained in N-methyl mesoporphyrin (NMM) IX, a GQ-specific dye. The gel was then stained with ethidium bromide (EtBr) to visualize all bands for comparison with the identified GQ bands.
SHMT1 RNA GR samples (15 μM) were prepared in 1/2× TBE. A GQ from the nuclear-enriched abundant transcript 1 (NEAT1) long noncoding RNA was used as a GQ-positive control, and the SARS-CoV-2 s2m as a GQ-negative control (Table ). The samples were prepared, run, and analyzed in the same manner as described above. All gels were performed at least in triplicate.
Circular Dichroism Spectroscopy
To investigate the topology of the GQ/iM formation, circular dichroism (CD) spectroscopy experiments were carried out using a Jasco J-810 spectropolarimeter at 25 °C. For GQ characterization, 10 μM of SHMT1 DNA GR was prepared in 200 μL of 10 mM cacodylic acid (pH 6.5), acquiring seven scans from 220 to 320 nm with a 1 s response time and a 2 nm bandwidth. The sample was then titrated with increasing concentrations of KCl (10, 25, 50, 100, and 150 mM KCl). The SHMT1 DNA GR data was smoothed using the Jasco spectra analysis Savitzky–Golay filter with a convolution width of 25. SHMT1 RNA GR was analyzed in the same manner.
For the iM characterization, the SHMT1 DNA CR sample was prepared in 10 mM cacodylic acid, and experiments were carried out at varying pH values (4.0, 5.5, 6.5, and 7.0). Spectra were collected from 220 to 340 nm (averaging seven scans) with a 1 s response time and a 2 nm bandwidth.
One-Dimensional Proton Nuclear Magnetic Resonance Spectroscopy
1D 1H NMR spectroscopy experiments were performed at 20 °C on a 500 MHz Bruker NMR spectrometer with Topspin 3.2 software (Bruker), utilizing the WATERGATE water suppression pulse sequence. 250 μM of SHMT1 DNA GR was prepared in 10 mM cacodylic acid (pH 6.5) in a final volume of 250 μL containing 10% D2O. Spectra were collected after titrating with each KCl concentration (0, 10, 25, 50, 100, and 150 mM). SHMT1 RNA GR (225 μM) was analyzed in the same manner.
The pH dependence of SHMT1 DNA CR was carried out by preparing a 250 μM sample in 10 mM cacodylic acid and 10% D2O in a final volume of 250 μL. Spectra were collected as described above but at various pH values (4.0, 5.5, 6.5, and 7.0).
Ultraviolet Thermal Denaturation Spectroscopy
UV thermal denaturation spectroscopy experiments were carried out using a Cary Series UV–vis spectrophotometer (Agilent Technologies). The stability of SHMT1 DNA GR was evaluated as a function of various KCl concentrations by monitoring the absorbance changes at 295 nm while increasing the temperature from 25 to 95 °C at a rate of 0.2 °C per minute. SHMT1 DNA GR was prepared at 10 μM and 200 μL in 10 mM cacodylic acid (pH 6.5), boiled for 5 min, and then cooled at 22 °C for 30 min. The protocol was repeated at each concentration of KCl (10, 25, 50, 100, and 150 mM). The same experiments were performed to evaluate SHMT1 RNA GR stability as a function of increasing KCl concentrations.
SHMT1 DNA CR was prepared at 10 μM and 200 μL in 10 mM cacodylic acid, boiled, and cooled at 22 °C for 30 min. The thermal denaturation experiments for this sample were performed at different pH values (4.0, 5.5, 6.5, and 7.0).
Thermodynamic parameters were obtained for GQ structures by fitting each UV thermal denaturation curve to eq , assuming a two-state model:
| 1 |
where A U and A F are the absorbances of the unfolded and native GQ, respectively, and R is the universal gas constant. Melting temperatures (T m) were calculated using eq :
| 2 |
The reported errors for the T m and thermodynamic parameters were calculated based on the errors from the fit of the thermal denaturation curves to eq .
The number of K+ ions bound exclusively by the GQ structure was calculated by assuming a folded-to-unfolded GQ model in which n K+ ions are released due to heat treatment and GQ unfolding. n is found as the slope of a plot of ΔG° as a function of the logarithm of K+ concentration (eq ):
| 3 |
where ln K eq = (ΔG/RT) and ΔΔG/Δ log[K+] refers to the slope of the plot of ΔG° as a function of the logarithm of K+ concentration.
Cell Culture
All cultures of A549 cells (gift from John Minna, University of Texas Southwestern Medical School) were grown in monolayer at 37 °C/5% carbon dioxide in the DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS; Corning Incorporated) and 100 units/mL penicillin and 100 μg/mL streptomycin sulfate (MP Biomedicals).
Molecular Cloning
To clone the 5′UTR of SHMT1 into pmirGLO (Promega), pmirGLO was digested with HindIII. The firefly luciferase gene was amplified using primers fLuc_F and fLuc_R (Table ) to introduce an EcoRI recognition site after the HindIII site. The SV40 poly(A) signal and promoter were amplified using primers SV40_F and SV40_R (Table ) such that HindIII was removed. These fragments were ligated into pmirGLO using HiFi assembly (New England Biolabs) to generate pmirGLO-5UTR. To generate the 5′UTR of SHMT1 (ENST00000316694.8), total RNA was isolated from A549 cells and used to generate complementary DNA (cDNA) by reverse transcription using the gene-specific primer SHMT1_R (Table ). Following amplification with primers SHMT1_F and SHMT1_R (Table ), the wild-type 5′UTR was ligated into pmirGLO-5UTR by HiFi assembly to generate pmirGLO-SHMT1. To generate mutant pmirGLO-SHMT1 (pmirGLO-SHMT1_MUT), which matches the G-rich mutant sequences described in the biophysical characterization, multisite directed mutagenesis was carried out by HiFi assembly using two fragments generated using primers SHMT1_F with Mut_R and SHMT1_R with Mut_F (Table ). All plasmid sequences were verified by whole plasmid sequencing (Eurofins Scientific).
2. Primer Sequences Used for SHMT1 Cloning, Luciferase Assay Preparation, and Reverse Transcription Quantitative Polymerase Chain Reactions.
| name | sequence |
|---|---|
| fLuc_F | CCTTTCGACCTGCAGCCCAAGCTTCATGTGATCCATGAATTCGGCAATCCGGTACTGTTG |
| fLuc_R | GCATGCCTGCAGGTC |
| SV40_F | GACCTGCAGGCATGC |
| SV40_R | GTTGTGTCAGAAGAATCATTTGCAAAAGCCTAGGCC |
| SHMT1_F | CCTTTCGACCTGCAGCCCAAGCTTAAGCCCAAGCTTGG |
| SHMT1_R | CAGTACCGGATTGCCGAATTCATGCACTTGTTCGAAGC |
| Mut_F | ACGCGTTGATTCAGCCTGTCTGACACTGGTGGCACCGG |
| Mut_R | GTCAGACAGCGTGAATCAACGCGTCGCGCACCGCC |
| fLuc1_F | GACACCGGTAAGACACTGGG |
| fLuc1_R | GCCTCGGGGTTGTTAACGTA |
| fLuc2_F | GTGCAGCGAGAATAGCTTGC |
| fLuc2_R | TTGCTCACGAATACGACGGT |
| fLuc3_F | TTCGGCAACCAGATCATCCC |
| fLuc3_R | AGATCAAGTAGCCCAGCGTG |
| rLuc1_F | GGAATGGGTAAGTCCGGCAA |
| rLuc1_R | CCAAGCGGTGAGGTACTTGT |
| rLuc2_F | CGCAACTACAACGCGTACCT |
| rLuc2_R | GCTCCCTCGACAATAGCGTT |
| rLuc3_F | CCATCGTCCATGCTGAGAGT |
| rLuc3_R | AGGGCGATATCCTCCTCGAT |
Dual Luciferase Assays
On day 0, A549 cells were set up at a density of 1.5 × 104 cells per well of a 96-well white plate (Corning Incorporated). The next day, cells were transfected with 300 ng of pmirGLO-SHMT1 or pmirGLO-SHMT1_MUT in 50 mL of growth medium using X-tremeGENE 9 (Sigma-Aldrich) according to the manufacturer’s protocol. After 72 h, firefly and Renilla luciferase activities were measured on a SpectraMax ID3 instrument (Molecular Device) using a Dual Luciferase Reporter Assay (Promega). Luminescence values were normalized by dividing the firefly by Renilla.
Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR)
On day 0, A549 cells were set up at a density of 4 × 105 cells per well of a six-well plate (Costar). The next day, cells were transfected with 1 μg of pmirGLO-5UTR, pmirGLO-SHMT1, or pmirGLO-SHMT1_MUT in 2 mL of growth medium using X-tremeGENE 9 according to the manufacturer’s protocol. After 72 h, RNA was extracted as described previously using TRIzol (Thermo Fisher) as per the manufacturer’s instruction and then treated with DNase I (Invitrogen). To prepare cDNA, 1 μg of RNA was reverse transcribed (SuperScript IV Reverse Transcriptase; Thermo Fisher) using 1 μL of 50 mM random hexamer primers (Invitrogen). For qPCR, cDNA samples were diluted 1:5 with nuclease-free water (Qiagen), and 1 μL was added to 5 μL of SYBR Green (Invitrogen), 1 μL of 10 mM primer pairs (Table ), and 3 μL of nuclease-free water. Following 40 cycles of amplification using a QuantStudio 3 Real-Time PCR System (Applied Biosystems), RT-qPCR data was analyzed by using the ΔΔCt method, where each RNA was normalized to pmirGLO-5UTR.
Supplementary Material
Acknowledgments
This work was supported by the National Institute of General Medical Sciences 2R15GM127307-05, the National Institute for Neurological Disorders and Stroke 5R25NS100118-07, and the National Science Foundation Research Experience for Undergraduates CHE-2244151.
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.5c13146.
Single- and double-stranded structure predictions for the SHMT1 GR_MUT sequence; native PAGE gel of the SHMT1 DNA GR sequence stained in NMM and ethidium bromide; single- and double-stranded structure predictions for the SHMT1 DNA CR_MUT sequence; and thermodynamic parameters calculated from UV thermal denaturation of SHMT1 DNA GR, select SHMT1 DNA CR, and SHMT1 RNA GR (PDF)
§.
R.M.P. and M.K. contributed equally to the work. M.-R.M. and D.B.H. conceived the presented idea and supervised the work. R.M.P., M.K., S.C.H., M.E.M., and Z.H.W. performed the experiments and data analysis. R.M.P. and M.K. wrote the initial manuscript and worked with M.E.M., D.B.H., and M.-R.M. for the preparation of the final manuscript.
The authors declare no competing financial interest.
References
- Haki M., Al-Biati H. A., Al-Tameemi Z. S., Ali I. S., Al-hussaniy H. A.. Review of Multiple Sclerosis: Epidemiology, Etiology, Pathophysiology, and Treatment. Medicine. 2024;103(8):e37297. doi: 10.1097/MD.0000000000037297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walton C., King R., Rechtman L., Kaye W., Leray E., Marrie R. A., Robertson N., La Rocca N., Uitdehaag B., van der Mei I., Wallin M., Helme A., Angood Napier C., Rijke N., Baneke P.. Rising Prevalence of Multiple Sclerosis Worldwide: Insights from the Atlas of MS, Third Edition. Mult. Scler. J. 2020;26(14):1816–1821. doi: 10.1177/1352458520970841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reich D. S., Lucchinetti C. F., Calabresi P. A.. Multiple Sclerosis. N. Engl. J. Med. 2018;378(2):169–180. doi: 10.1056/nejmra1401483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olsson T., Barcellos L. F., Alfredsson L.. Interactions between Genetic, Lifestyle and Environmental Risk Factors for Multiple Sclerosis. Nat. Rev. Neurol. 2017;13(1):25–36. doi: 10.1038/nrneurol.2016.187. [DOI] [PubMed] [Google Scholar]
- Huynh J. L., Casaccia P.. Epigenetic Mechanisms in Multiple Sclerosis: Implications for Pathogenesis and Treatment. Lancet Neurol. 2013;12(3):195–206. doi: 10.1016/S1474-4422(12)70309-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sawcer S., Franklin R. J. M., Ban M.. Multiple Sclerosis Genetics. Lancet Neurol. 2014;13(7):700–709. doi: 10.1016/S1474-4422(14)70041-9. [DOI] [PubMed] [Google Scholar]
- Crider K. S., Yang T. P., Berry R. J., Bailey L. B.. Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate’s Role. Adv. Nutr. 2012;3(1):21–38. doi: 10.3945/an.111.000992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Celarain N., Tomas-Roig J.. Aberrant DNA Methylation Profile Exacerbates Inflammation and Neurodegeneration in Multiple Sclerosis Patients. J. Neuroinflammation. 2020;17(1):1–17. doi: 10.1186/s12974-019-1667-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sokratous M., Dardiotis E., Tsouris Z., Bellou E., Michalopoulou A., Siokas V., Arseniou S., Stamati T., Tsivgoulis G., Bogdanos D., Hadjigeorgiou G. M.. Deciphering the Role of DNA Methylation in Multiple Sclerosis: Emerging Issues. Autoimmun. Highlights. 2016;7(1):1–9. doi: 10.1007/s13317-016-0084-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ineichen B. V., Keskitalo S., Farkas M., Bain N., Kallweit U., Weller M., Klotz L., Linnebank M.. Genetic Variants of Homocysteine Metabolism and Multiple Sclerosis: A Case-Control Study. Neurosci. Lett. 2014;562:75–78. doi: 10.1016/j.neulet.2014.01.008. [DOI] [PubMed] [Google Scholar]
- Ma Q., Shams H., Didonna A., Baranzini S. E., Cree B. A. C., Hauser S. L., Henry R. G., Oksenberg J. R.. Integration of Epigenetic and Genetic Profiles Identifies Multiple Sclerosis Disease-Critical Cell Types and Genes. Commun. Biol. 2023;6(1):1–10. doi: 10.1038/s42003-023-04713-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chomyk A. M., Volsko C., Tripathi A., Deckard S. A., Trapp B. D., Fox R. J., Dutta R.. DNA Methylation in Demyelinated Multiple Sclerosis Hippocampus. Sci. Rep. 2017;7(1):1–10. doi: 10.1038/s41598-017-08623-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fagone P., Mangano K., di Marco R., Touil-Boukoffa C., Chikovan T., Signorelli S., Lombardo G. A. G., Patti F., Mammana S., Nicoletti F.. Expression of DNA Methylation Genes in Secondary Progressive Multiple Sclerosis. J. Neuroimmunol. 2016;290:66–69. doi: 10.1016/j.jneuroim.2015.11.018. [DOI] [PubMed] [Google Scholar]
- Jia T., Ma Y., Qin F., Han F., Zhang C.. Brain Proteome-Wide Association Study Linking-Genes in Multiple Sclerosis Pathogenesis. Ann. Clin. Transl. Neurol. 2023;10(1):58–69. doi: 10.1002/acn3.51699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andlauer T. F. M., Buck D., Antony G., Bayas A., Bechmann L., Berthele A., Chan A., Gasperi C., Gold R., Graetz C., Haas J., Hecker M., Infante-Duarte C., Knop M., Kümpfel T., Limmroth V., Linker R. A., Loleit V., Luessi F., Meuth S. G., Mühlau M., Nischwitz S., Paul F., Pütz M., Ruck T., Salmen A., Stangel M., Stellmann J. P., Stürner K. H., Tackenberg B., Then Bergh F., Tumani H., Warnke C., Weber F., Wiendl H., Wildemann B., Zettl U. K., Ziemann U., Zipp F., Arloth J., Weber P., Radivojkov-Blagojevic M., Scheinhardt M. O., Dankowski T., Bettecken T., Lichtner P., Czamara D., Carrillo-Roa T., Binder E. B., Berger K., Bertram L., Franke A., Gieger C., Herms S., Homuth G., Ising M., Jöckel K. H., Kacprowski T., Kloiber S., Laudes M., Lieb W., Lill C. M., Lucae S., Meitinger T., Moebus S., Müller-Nurasyid M., Nöthen M. M., Petersmann A., Rawal R., Schminke U., Strauch K., Völzke H., Waldenberger M., Wellmann J., Porcu E., Mulas A., Pitzalis M., Sidore C., Zara I., Cucca F., Zoledziewska M., Ziegler A., Hemmer B., Müller-Myhsok B.. Novel Multiple Sclerosis Susceptibility Loci Implicated in Epigenetic Regulation. Sci. Adv. 2016;2(6):e1501678. doi: 10.1126/sciadv.1501678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Webb L. M., Guerau-de-Arellano M.. Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA. Trends Mol. Med. 2017;23(6):546–562. doi: 10.1016/j.molmed.2017.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu W., Guo J., Lu W., Cheng T., Li Y., Xian M., Zhang R.. Improved Methyl Supply for 5-Methyltetrahydrofolate Production in E. Coli through a Novel C1 Transfer Pathway. Microb. Cell Fact. 2025;24(1):83. doi: 10.1186/s12934-025-02707-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoogsteen K.. The Structure of Crystals Containing a Hydrogen-Bonded Complex of 1-Methylthymine and 9-Methyladenine. Acta Crystallogr. 1959;12(10):822–823. doi: 10.1107/S0365110X59002389. [DOI] [Google Scholar]
- Hoogsteen K.. The Crystal and Molecular Structure of a Hydrogen-Bonded Complex between 1-Methylthymine and 9-Methyladenine. Acta Crystallogr. 1963;16(9):907–916. doi: 10.1107/S0365110X63002437. [DOI] [Google Scholar]
- Murat P., Balasubramanian S.. Existence and Consequences of G-Quadruplex Structures in DNA. Curr. Opin. Genet. Dev. 2014;25(1):22–29. doi: 10.1016/j.gde.2013.10.012. [DOI] [PubMed] [Google Scholar]
- Chambers V. S., Marsico G., Boutell J. M., Di Antonio M., Smith G. P., Balasubramanian S.. High-Throughput Sequencing of DNA G-Quadruplex Structures in the Human Genome. Nat. Biotechnol. 2015;33(8):877–881. doi: 10.1038/nbt.3295. [DOI] [PubMed] [Google Scholar]
- Izatt R. M., Christensen J. J., Rytting J. H.. Erratum: Sites and Thermodynamic Quantities Associated with Proton and Metal Ion Interaction with Ribonucleic Acid, Deoxyribonucleic Acid, and Their Constituent Bases, Nucleosides, and Nucleotides (Chemical Reviews (1971) 71 (449–477)) Chem. Rev. 1972;72(6):720. doi: 10.1021/cr60280a005. [DOI] [PubMed] [Google Scholar]
- Abou Assi H., Garavís M., González C., Damha M. J.. I-Motif DNA: Structural Features and Significance to Cell Biology. Nucleic Acids Res. 2018;46(16):8038–8056. doi: 10.1093/nar/gky735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peña Martinez C. D., Zeraati M., Rouet R., Mazigi O., Henry J. Y., Gloss B., Kretzmann J. A., Evans C. W., Ruggiero E., Zanin I., Marušič M., Plavec J., Richter S. N., Bryan T. M., Smith N. M., Dinger M. E., Kummerfeld S., Christ D.. Human Genomic DNA Is Widely Interspersed with I-Motif Structures. EMBO J. 2024;43(20):4786–4804. doi: 10.1038/s44318-024-00210-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zeraati M., Langley D. B., Schofield P., Moye A. L., Rouet R., Hughes W. E., Bryan T. M., Dinger M. E., Christ D.. I-Motif DNA Structures Are Formed in the Nuclei of Human Cells. Nat. Chem. 2018;10(6):631–637. doi: 10.1038/s41557-018-0046-3. [DOI] [PubMed] [Google Scholar]
- Saxena S., Joshi S., Shankaraswamy J., Tyagi S., Kukreti S.. Magnesium and Molecular Crowding of the Cosolutes Stabilize the I-Motif Structure at Physiological PH. Biopolymers. 2017;107(7):e23018. doi: 10.1002/bip.23018. [DOI] [PubMed] [Google Scholar]
- Cui Y., Kong D., Ghimire C., Xu C., Mao H.. Mutually Exclusive Formation of G-Quadruplex and i-Motif Is a General Phenomenon Governed by Steric Hindrance in Duplex DNA. Biochemistry. 2016;55(15):2291–2299. doi: 10.1021/acs.biochem.6b00016. [DOI] [PubMed] [Google Scholar]
- Spiegel J., Cuesta S. M., Adhikari S., Hänsel-Hertsch R., Tannahill D., Balasubramanian S.. G-Quadruplexes Are Transcription Factor Binding Hubs in Human Chromatin. Genome Biol. 2021;22(1):1–15. doi: 10.1186/s13059-021-02324-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutherland C., Cui Y., Mao H., Hurley L. H.. A Mechanosensor Mechanism Controls the G-Quadruplex/i-Motif Molecular Switch in the MYC Promoter NHE III1. J. Am. Chem. Soc. 2016;138(42):14138–14151. doi: 10.1021/jacs.6b09196. [DOI] [PubMed] [Google Scholar]
- Kaulage M. H., Bhattacharya S., Muniyappa K.. Structural Characterization of I-Motif Structure in the Human Acetyl-CoA Carboxylase 1 Gene Promoters and Their Role in the Regulation of Gene Expression. ChemBioChem. 2018;19(10):1078–1087. doi: 10.1002/cbic.201800021. [DOI] [PubMed] [Google Scholar]
- Kharel P., Becker G., Tsvetkov V., Ivanov P.. Properties and Biological Impact of RNA G-Quadruplexes: From Order to Turmoil and Back. Nucleic Acids Res. 2020;48(22):12534–12555. doi: 10.1093/nar/gkaa1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cammas A., Millevoi S.. RNA G-Quadruplexes: Emerging Mechanisms in Disease. Nucleic Acids Res. 2017;45(4):1584–1595. doi: 10.1093/nar/gkw1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dumas L., Herviou P., Dassi E., Cammas A., Millevoi S. G.-.. Quadruplexes in RNA Biology: Recent Advances and Future Directions. Trends Biochem. Sci. 2021;46(4):270–283. doi: 10.1016/j.tibs.2020.11.001. [DOI] [PubMed] [Google Scholar]
- Agarwala P., Pandey S., Maiti S.. The Tale of RNA G-Quadruplex. Org. Biomol. Chem. 2015;13(20):5570–5585. doi: 10.1039/C4OB02681K. [DOI] [PubMed] [Google Scholar]
- Kikin O., D’Antonio L., Bagga P. S.. QGRS Mapper: A Web-Based Server for Predicting G-Quadruplexes in Nucleotide Sequences. Nucleic Acids Res. 2006;34:W676–W682. doi: 10.1093/nar/gkl253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stefanovic S., Bassell G. J., Mihailescu M. R. G.. Quadruplex RNA Structures in PSD-95 MRNA: Potential Regulators of MiR-125a Seed Binding Site Accessibility. RNA. 2015;21(1):48–60. doi: 10.1261/rna.046722.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y., Gaetano C. M., Williams K. R., Bassell G. J., Mihailescu M. R.. FMRP Interacts with G-Quadruplex Structures in the 3 ′-UTR of Its Dendritic Target Shank1MRNA. RNA Biol. 2014;11(11):1364–1374. doi: 10.1080/15476286.2014.996464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fürtig B., Richter C., Wöhnert J., Schwalbe H.. NMR Spectroscopy of RNA. ChemBioChem. 2003;4(10):936–962. doi: 10.1002/cbic.200300700. [DOI] [PubMed] [Google Scholar]
- Yang D.. G-Quadruplex DNA and RNA. Methods Mol. Biol. 2019;2035:1–24. doi: 10.1007/978-1-4939-9666-7_1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dapić V., Abdomerović V., Marrington R., Peberdy J., Rodger A., Trent J. O., Bates P. J.. Biophysical and Biological Properties of Quadruplex Oligodeoxyribonucleotides. Nucleic Acids Res. 2003;31(8):2097–2107. doi: 10.1093/nar/gkg316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- del Villar-Guerra R., Trent J. O., Chaires J. B.. G-Quadruplex Secondary Structure Obtained from Circular Dichroism Spectroscopy. Angew. Chem., Int. Ed. 2018;57(24):7171–7175. doi: 10.1002/anie.201709184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicoludis J. M., Barrett S. P., Mergny J. L., Yatsunyk L. A.. Interaction of Human Telomeric DNA with N-Methyl Mesoporphyrin IX. Nucleic Acids Res. 2012;40(12):5432–5447. doi: 10.1093/nar/gks152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yett, A. ; Lin, L. Y. ; Beseiso, D. ; Miao, J. ; Yatsunyk, L. A. . N-Methyl Mesoporphyrin IX as a Highly Selective Light-up Probe for G-Quadruplex DNA. In Porphyrin Science By Women (In 3 Volumes); World Scientific Publishing, 2020; pp 141–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mergny J.-L., Phan A., Lacroix L.. Following G-Quartet Formation by UV-Spectroscopy. FEBS Lett. 1998;435:74–78. doi: 10.1016/S0014-5793(98)01043-6. [DOI] [PubMed] [Google Scholar]
- Hardin C. C., Perry A. G., White K.. Thermodynamic and Kinetic Characterization of the Dissociation and Assembly of Quadruplex Nucleic Acids. Biopolymers. 2000;56(3):147–194. doi: 10.1002/1097-0282(2000/2001)56:3<147::AID-BIP10011>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
- Bhattacharya P. K., Cha J., Barton J. K.. 1H NMR Determination of Base-Pair Lifetimes in Oligonucleotides Containing Single Base Mismatches. Nucleic Acids Res. 2002;30(21):4740–4750. doi: 10.1093/nar/gkf601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cortolezzis Y., Othman Z., Agostini F., Ibrahim I., Picco R., Salgado G. F., Di Giorgio E., Xodo L. E.. Post-Transcriptional Control of KRAS: Functional Roles of 5′UTR RNA G-Quadruplexes, Long Noncoding RNA, and HnRNPA1. Nucleic Acids Res. 2025;53(17):gkaf886. doi: 10.1093/nar/gkaf886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang C. F., Shafer R. H.. Engineering the Quadruplex Fold: Nucleoside Conformation Determines Both Folding Topology and Molecularity in Guanine Quadruplexes. J. Am. Chem. Soc. 2006;128(17):5966–5973. doi: 10.1021/ja0603958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fay M. M., Lyons S. M., Ivanov P.. RNA G-Quadruplexes in Biology: Principles and Molecular Mechanisms. J. Mol. Biol. 2017;429(14):2127–2147. doi: 10.1016/j.jmb.2017.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joachimi A., Benz A., Hartig J. S.. A Comparison of DNA and RNA Quadruplex Structures and Stabilities. Bioorg. Med. Chem. 2009;17(19):6811–6815. doi: 10.1016/j.bmc.2009.08.043. [DOI] [PubMed] [Google Scholar]
- Parkinson G. N., Lee M. P. H., Neidle S.. Crystal Structure of Parallel Quadruplexes from Human Telomeric DNA. Nature. 2002;417(6891):876–880. doi: 10.1038/nature755. [DOI] [PubMed] [Google Scholar]
- Zanin I., Ruggiero E., Nicoletto G., Lago S., Maurizio I., Gallina I., Richter S. N.. Genome-Wide Mapping of i-Motifs Reveals Their Association with Transcription Regulation in Live Human Cells. Nucleic Acids Res. 2023;51(16):8309–8321. doi: 10.1093/nar/gkad626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kharel P., Fay M., Manasova E. V., Anderson P. J., Kurkin A. V., Guo J. U., Ivanov P.. Stress Promotes RNA G-Quadruplex Folding in Human Cells. Nat. Commun. 2023;14(1):1–10. doi: 10.1038/s41467-023-35811-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zapanti E., Dermentzoglou A., Kazakou P., Kilindireas K., Mastorakos G.. The Role of the Stress Adaptive Response in Multiple Sclerosis. Front. Neuroendocrinol. 2025;78(March):101204. doi: 10.1016/j.yfrne.2025.101204. [DOI] [PubMed] [Google Scholar]
- Piñar-Morales R., Durán R., Bautista-García A., García-Mansilla M. J., Aliaga-Gaspar P., Vives-Montero F., Barrero-Hernández F. J.. The Impact of Oxidative Stress on Symptoms Associated with Multiple Sclerosis. Sci. Rep. 2025;15(1):1–12. doi: 10.1038/s41598-025-07429-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lago S., Nadai M., Ruggiero E., Tassinari M., Marušič M., Tosoni B., Frasson I., Cernilogar F. M., Pirota V., Doria F., Plavec J., Schotta G., Richter S. N.. The MDM2 Inducible Promoter Folds into Four-Tetrad Antiparallel G-Quadruplexes Targetable to Fight Malignant Liposarcoma. Nucleic Acids Res. 2021;49(2):847–863. doi: 10.1093/nar/gkaa1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang J., Qin G., Niu J., Wei Y., Li X., Zhao C., Wang C., Ren J., Qu X.. Targeting G-Quadruplexes in an Ageing Epigenetic Regulator Promoter for Rescuing Mitochondrial Dysfunction in Alzheimer’s Disease. Chem. Commun. 2023;59(8):1078–1081. doi: 10.1039/D2CC05957F. [DOI] [PubMed] [Google Scholar]
- Huppert J. L., Bugaut A., Kumari S., Balasubramanian S.. G-Quadruplexes: The Beginning and End of UTRs. Nucleic Acids Res. 2008;36(19):6260–6268. doi: 10.1093/nar/gkn511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jodoin R., Carrier J. C., Rivard N., Bisaillon M., Perreault J. P.. G-Quadruplex Located in the 5UTR of the BAG-1 MRNA Affects Both Its Cap-Dependent and Cap-Independent Translation through Global Secondary Structure Maintenance. Nucleic Acids Res. 2019;47(19):10247–10266. doi: 10.1093/nar/gkz777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gonçalves D. P. N., Rodriguez R., Balasubramanian S., Sanders J. K. M.. Tetramethylpyridiniumporphyrazines - A New Class of G-Quadruplex Inducing and Stabilising Ligands. Chem. Commun. 2006;2(45):4685–4687. doi: 10.1039/B611731G. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Izbicka E., Wheelhouse R. T., Raymond E., Davidson K. K., Lawrence R. A., Sun D., Windle B. E., Hurley L. H., Von Hoff D. D.. Effects of Cationic Porphyrins as G-Quadruplex Interactive Agents in Human Tumor Cells. Cancer Res. 1999;59(3):639–644. [PubMed] [Google Scholar]
- Psaras A. M., Chang K. T., Hao T., Brooks T. A.. Targeted Downregulation of MYC through G-Quadruplex Stabilization by DNAi. Molecules. 2021;26:5542. doi: 10.3390/molecules26185542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Menon L., Mader S. A., Mihailescu M. R.. Fragile X Mental Retardation Protein Interactions with the Microtubule Associated Protein 1B RNA. RNA. 2008;14(8):1644–1655. doi: 10.1261/rna.1100708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hyder U., Challa A., Thornton M., Nandu T., Kraus W. L., D’Orso I.. KAP1 Negatively Regulates RNA Polymerase II Elongation Kinetics to Activate Signal-Induced Transcription. Nat. Commun. 2024;15(1):1–20. doi: 10.1038/s41467-024-49905-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


